Scientists have unveiled clues into why some cancer patients develop a serious heart condition after chemotherapy. The new research, from a team of international scientists led by Imperial College London, Royal Brompton Hospital and the MRC London Institute of Medical Sciences, shows the heart condition may be linked to a faulty gene called titin. In […]

A team of scientists led by Imperial College London have discovered a new strain of group A streptococcus bacteria. Group A streptococcus (or Strep A) is known to cause scarlet fever, throat infections and – in very rare cases – invasive disease, where the bacterium enters the bloodstream or tissue and can trigger sepsis and […]

Scientists have visualised for the first time protein ‘tangles’ associated with dementia in patients who have suffered a single head injury. This is the finding of a new study led by scientists from Imperial College London, published in the journal Science Translational Medicine. In the early-stage study, researchers studied 21 patients who had suffered a moderate to […]

Cancer patients on immunotherapy fare worse if they have recently taken antibiotics, with their response and overall survival rate ‘crashing’. The findings come from a study of almost 200 cancer patients in the UK taking a type of immunotherapy called checkpoint inhibitors, part of the standard treatment pathway for cancer patients on the NHS. Researchers […]

Are you a patient, carer, research or healthcare professional, or member of the public? Are you interested in clinical and health-related research? Visit our free Open Day to see demonstrations of the world-class science happening at Imperial The National Institute for Health Research (NIHR) is the largest funder of health and care research in the […]

Last month NIHR Imperial BRC welcomed Venture Capital investors Syncona at a pitching and networking event, organised by colleagues at Imperial’s Industry Partnerships and Commercialisation Team. Syncona is a life sciences investment company founded by the Wellcome Trust, and its goal is to build standalone healthcare companies that can deliver transformative treatments to patients. Their […]

Scientists have successfully used microneedle biosensors to accurately detect changes in antibiotic levels in the body for the first time. Small, non-invasive patches worn on the skin can accurately detect the levels of medication in a patient’s system, matching the accuracy of current clinical methods. In a small-scale clinical evaluation, researchers at Imperial College London […]